RAPT Therapeutics Inc (RAPT)
1.38
-0.19
(-12.10%)
USD |
NASDAQ |
Nov 14, 12:01
RAPT Therapeutics Total Assets (Quarterly): 127.18M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 127.18M |
| March 31, 2024 | 155.82M |
| December 31, 2023 | 173.33M |
| September 30, 2023 | 199.72M |
| June 30, 2023 | 220.76M |
| March 31, 2023 | 248.33M |
| December 31, 2022 | 266.21M |
| September 30, 2022 | 209.49M |
| June 30, 2022 | 222.00M |
| March 31, 2022 | 187.55M |
| December 31, 2021 | 198.64M |
| September 30, 2021 | 217.46M |
| Date | Value |
|---|---|
| June 30, 2021 | 231.08M |
| March 31, 2021 | 105.92M |
| December 31, 2020 | 118.97M |
| September 30, 2020 | 128.97M |
| June 30, 2020 | 139.68M |
| March 31, 2020 | 150.89M |
| December 31, 2019 | 84.60M |
| September 30, 2019 | 58.37M |
| June 30, 2019 | 68.11M |
| March 31, 2019 | 67.86M |
| December 31, 2018 | 69.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
84.60M
Minimum
Dec 2019
266.21M
Maximum
Dec 2022
178.24M
Average
187.55M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| Arbutus Biopharma Corp | 140.44M |
| GlycoMimetics Inc | 24.42M |
| FibroGen Inc | 293.20M |
| Cidara Therapeutics Inc | 173.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.96M |
| Shareholders Equity (Quarterly) | 109.22M |